(MedPage Today) — An established blood thinner regimen failed to extend its cardioprotective benefits to patients with advanced chronic kidney disease (CKD), according to the international TRACK trial.
In this placebo-controlled study of patients…
Source link
Trial Dims Prospects for Rivaroxaban's Cardiovascular Protection in Advanced CKD
Show Comments (0)
Hide Comments (0)
0
0
votes
Article Rating
Subscribe
Login
0 Comments
Oldest
Newest
Most Voted
Inline Feedbacks
View all comments
